Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue 
Nvidia Appoints Former Google Executive Alison Wagonfeld as First Chief Marketing Officer 
Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal 
Chevron Seeks Expanded U.S. License to Boost Venezuelan Oil Exports Amid Sanctions Talks 
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability 
Anthropic Launches HIPAA-Compliant Healthcare Tools for Claude AI Amid Growing Competition 
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move 
SK Hynix Shares Hit Record High as AI Memory Demand Fuels Semiconductor Rally 
China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges 
EU Orders Elon Musk’s X to Preserve Grok AI Data Amid Probe Into Illegal Content 
Ford Targets Level 3 Autonomous Driving by 2028 with New EV Platform and AI Innovations 
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids 
Hanwha Ocean Shares Rise on Plans to Expand U.S. Shipbuilding Capacity 
Trump Weighs Blocking Exxon Investment as Venezuela Deemed “Uninvestable” 
xAI Cash Burn Highlights the High Cost of Competing in Generative AI 
AustralianSuper Backs BlueScope Steel’s Rejection of $9 Billion Takeover Bid 
BRIGHTON, Colo., March 19, 2017 -- Brighton Eye Associates is pleased to announce to the community the introduction of the High Definition CIRRUS HD-OCT technology as part of an enhanced eye examination. The Ocular Coherence Tomography or OCT provides a microscopic 3-D evaluation of the eye. Especially important is its use for macular degeneration and for glaucoma. It is also valuable for other eye conditions including diabetes and high blood pressure. Doctors are able to see the difference between wet macular degeneration and dry macular degeneration.
Glaucoma is usually seen in people over the age of 40. People do not know they have glaucoma because it has no symptoms. Early detection, monitoring, and treatment slows the progress of glaucoma. The new High Definition CIRRUS HD-OCT instrument allows for a 3D examination of the eye and much earlier diagnosis of glaucoma.
“We are excited to offer the new HD OCT instrument to our patients,” said Dr. Rodney D. Fair, OD. “Dr. Baker, Dr. Sanchez and I are always looking for better ways to serve the vision needs of our patients and this instrument is the latest addition to our state-of-the-art technology used to help our patients at Brighton Eye Associates.”
Visit http://brightoneye.net/ for more details.
Brighton Eye Associates 1001 E. Bridge Street Brighton, CO 80601 (303) 659-3036
